BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 8795671)

  • 1. Evidence for a relation between metabolic derangements and increased levels of inflammatory mediators in a subgroup of patients with chronic obstructive pulmonary disease.
    Schols AM; Buurman WA; Staal van den Brekel AJ; Dentener MA; Wouters EF
    Thorax; 1996 Aug; 51(8):819-24. PubMed ID: 8795671
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systemic anti-inflammatory mediators in COPD: increase in soluble interleukin 1 receptor II during treatment of exacerbations.
    Dentener MA; Creutzberg EC; Schols AM; Mantovani A; van't Veer C; Buurman WA; Wouters EF
    Thorax; 2001 Sep; 56(9):721-6. PubMed ID: 11514694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased resting energy expenditure and weight loss are related to a systemic inflammatory response in lung cancer patients.
    Staal-van den Brekel AJ; Dentener MA; Schols AM; Buurman WA; Wouters EF
    J Clin Oncol; 1995 Oct; 13(10):2600-5. PubMed ID: 7595713
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The relationship between chronic hypoxemia and activation of the tumor necrosis factor-alpha system in patients with chronic obstructive pulmonary disease.
    Takabatake N; Nakamura H; Abe S; Inoue S; Hino T; Saito H; Yuki H; Kato S; Tomoike H
    Am J Respir Crit Care Med; 2000 Apr; 161(4 Pt 1):1179-84. PubMed ID: 10764309
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of TNF-α, sTNF-R55 and sTNF-R75 in inflammation of acute exacerbations of chronic obstructive pulmonary disease.
    Zeng M; Wen Y; Liu LY; Wang H; Guan KP; Huang X
    Respiration; 2009; 78(4):399-403. PubMed ID: 19339767
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of treatment with chemotherapy on energy metabolism and inflammatory mediators in small-cell lung carcinoma.
    Staal-van den Brekel AJ; Schols AM; Dentener MA; ten Velde GP; Buurman WA; Wouters EF
    Br J Cancer; 1997; 76(12):1630-5. PubMed ID: 9413953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of an elevated resting energy expenditure in patients with chronic obstructive pulmonary disease in relation to body composition and lung function.
    Creutzberg EC; Schols AM; Bothmer-Quaedvlieg FC; Wouters EF
    Eur J Clin Nutr; 1998 Jun; 52(6):396-401. PubMed ID: 9683390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Soluble TNF-alpha receptor and IL-1 receptor antagonist elevation in BAL in active pulmonary TB.
    Tsao TC; Li L; Hsieh M; Liao S; Chang KS
    Eur Respir J; 1999 Sep; 14(3):490-5. PubMed ID: 10543265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipopolysaccharide LPS-mediated soluble TNF receptor release and TNF receptor expression by monocytes. Role of CD14, LPS binding protein, and bactericidal/permeability-increasing protein.
    Leeuwenberg JF; Dentener MA; Buurman WA
    J Immunol; 1994 May; 152(10):5070-6. PubMed ID: 7513728
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolism in patients with small cell lung carcinoma compared with patients with non-small cell lung carcinoma and healthy controls.
    Staal-van den Brekel AJ; Schols AM; Dentener MA; ten Velde GP; Buurman WA; Wouters EF
    Thorax; 1997 Apr; 52(4):338-41. PubMed ID: 9196516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Soluble tumor necrosis factor receptors in chronic hepatitis C: a correlation with histological fibrosis and activity.
    Zylberberg H; Rimaniol AC; Pol S; Masson A; De Groote D; Berthelot P; Bach JF; Bréchot C; Zavala F
    J Hepatol; 1999 Feb; 30(2):185-91. PubMed ID: 10068094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating leptin in patients with chronic obstructive pulmonary disease.
    Takabatake N; Nakamura H; Abe S; Hino T; Saito H; Yuki H; Kato S; Tomoike H
    Am J Respir Crit Care Med; 1999 Apr; 159(4 Pt 1):1215-9. PubMed ID: 10194168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Weight loss and low body cell mass in males with lung cancer: relationship with systemic inflammation, acute-phase response, resting energy expenditure, and catabolic and anabolic hormones.
    Simons JP; Schols AM; Buurman WA; Wouters EF
    Clin Sci (Lond); 1999 Aug; 97(2):215-23. PubMed ID: 10409477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating levels of soluble Fas ligand and soluble Fas in patients with chronic obstructive pulmonary disease.
    Takabatake N; Nakamura H; Inoue S; Terashita K; Yuki H; Kato S; Yasumura S; Tomoike H
    Respir Med; 2000 Dec; 94(12):1215-20. PubMed ID: 11192958
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor necrosis factor alpha and interleukin-1 alpha stimulate late shedding of p75 TNF receptors but not p55 TNF receptors from human monocytes.
    Joyce DA; Steer JH
    J Interferon Cytokine Res; 1995 Nov; 15(11):947-54. PubMed ID: 8590306
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Local and systemic inflammation in patients with chronic obstructive pulmonary disease: soluble tumor necrosis factor receptors are increased in sputum.
    Vernooy JH; Küçükaycan M; Jacobs JA; Chavannes NH; Buurman WA; Dentener MA; Wouters EF
    Am J Respir Crit Care Med; 2002 Nov; 166(9):1218-24. PubMed ID: 12403691
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum values of tumour necrosis factor-alpha and of soluble tumour necrosis factor-R55 in melanoma patients.
    Ocvirk J; Stabuc B; Rudolf Z; Galvani V; Curin-Serbec V
    Melanoma Res; 2000 Jun; 10(3):253-8. PubMed ID: 10890379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma leptin is related to proinflammatory status and dietary intake in patients with chronic obstructive pulmonary disease.
    Schols AM; Creutzberg EC; Buurman WA; Campfield LA; Saris WH; Wouters EF
    Am J Respir Crit Care Med; 1999 Oct; 160(4):1220-6. PubMed ID: 10508810
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated serum tumor necrosis factor-alpha and soluble tumor necrosis factor receptors correlate with aberrant energy metabolism in liver cirrhosis.
    Shiraki M; Terakura Y; Iwasa J; Shimizu M; Miwa Y; Murakami N; Nagaki M; Moriwaki H
    Nutrition; 2010 Mar; 26(3):269-75. PubMed ID: 19695831
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytokine-driven inflammatory response is associated with the hypermetabolism of AIDS patients with opportunistic infections.
    García-Lorda P; Serrano P; Jiménez-Expósito MJ; Fraile J; Bulló M; Alonso C; Bonada A; Viciana P; Luna PP; Salas-Salvadó J
    JPEN J Parenter Enteral Nutr; 2000; 24(6):317-22. PubMed ID: 11071589
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.